Publication date: Sep 23, 2025
Telemedicine use has risen significantly since the COVID-19 pandemic. Evidence suggests that the quality of care in telemedicine could be as good as in-person care, but this is likely context-dependent. Expert guidelines have declared the appropriate medical conditions, but often without empirical evidence that grapples with the fundamental information limitations facing telemedicine. We draw on the task-technology fit theory and empirical evidence around human communication to examine how the medical and social contexts affect the efficiency and clinical quality of primary care. We will use a population-based dataset from the Canadian province of British Columbia (BC) to inform a quasi-experimental study using propensity score matching (PSM). The treatment group will consist of telemedicine visits from April to December 2022. We will use PSM to create a control group of matched, in-person visits in the same period. We will then use cluster-robust linear regression to identify how specific medical conditions and social contexts are associated with higher rates of prescription, follow-up with primary care providers, emergency department visits and acute care admissions. We plan for the study to take place from 1 August 2025 to 1 August 2026. The Research Ethics BC has granted approval for this study (H21-02244-A006). Our findings will be shared with patients, healthcare providers and policymakers and disseminated through conference presentations and peer-reviewed publications.
Open Access PDF
Semantics
| Type | Source | Name |
|---|---|---|
| disease | IDO | quality |
| disease | MESH | COVID-19 pandemic |
| disease | MESH | emergency |
| disease | MESH | pneumonia |
| drug | DRUGBANK | Indoleacetic acid |
| disease | IDO | history |
| disease | MESH | eczema |
| disease | MESH | psoriasis |
| disease | MESH | depression |
| disease | MESH | chest pain |
| disease | MESH | complications |
| disease | MESH | anxiety |
| disease | MESH | acne |
| disease | MESH | upper respiratory infections |
| disease | MESH | infections |
| drug | DRUGBANK | Isoxaflutole |
| disease | MESH | anxiety disorder |
| disease | MESH | Privacy |
| drug | DRUGBANK | Aspartame |
| disease | MESH | morbidity |
| disease | MESH | Comorbidity |
| drug | DRUGBANK | Vildagliptin |